Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.2400
+0.00642.74%
Post-market: 0.24010.0001+0.04%19:59 EDT
Volume:718.61K
Turnover:175.61K
Market Cap:10.65M
PE:-0.14
High:0.2532
Open:0.2340
Low:0.2340
Close:0.2336
52wk High:5.14
52wk Low:0.1980
Shares:44.38M
Float Shares:41.42M
Volume Ratio:2.16
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6559
EPS(LYR):-1.8303
ROE:-166.46%
ROA:-83.21%
PB:0.44
PE(LYR):-0.13

Loading ...

Apr 29, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 02, 2021

Major Issues Report

8-K - Current report
Jan 22, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]